Type: Rectal cancer
This research has revealed a significant increase in rates of anal cancer in high-income countries, including Australia, since the late 1980s.
This SPAR trial will test whether taking a statin for 3 months during and after cancer treatment improves the response of a rectal tumour to radiation and chemotherapy.